Cargando…

Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews

BACKGROUND: The demand for clinical trial participants is today one of the highest it has ever been and continues to increase. At the same time, subject recruitment continues to be problematic and the major reason for clinical trial premature terminations. The literature on clinical trial recruitmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Torres, Edgardo, González-Pérez, Margarita M., Díaz-Pérez, Clemente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358641/
https://www.ncbi.nlm.nih.gov/pubmed/34401599
http://dx.doi.org/10.1016/j.conctc.2021.100829
_version_ 1783737385025011712
author Rodríguez-Torres, Edgardo
González-Pérez, Margarita M.
Díaz-Pérez, Clemente
author_facet Rodríguez-Torres, Edgardo
González-Pérez, Margarita M.
Díaz-Pérez, Clemente
author_sort Rodríguez-Torres, Edgardo
collection PubMed
description BACKGROUND: The demand for clinical trial participants is today one of the highest it has ever been and continues to increase. At the same time, subject recruitment continues to be problematic and the major reason for clinical trial premature terminations. The literature on clinical trial recruitment, which spans several decades and includes hundreds of studies, has an abundance of findings that can be synthesized by way of an overview to provide a well-informed and complete picture of the factors that determine subject participation. OBJECTIVES: An overview of the systematic reviews that report barriers and facilitators to clinical trial participation was conducted. The extracted data were synthesized, and a thematic framework of the factors that affect subject participation in clinical trials was developed. The overview extended across medical subjects and demographics. METHODS: Thirty reviews that complied with the inclusion criteria were included. These reviews covered 753 relevant primary studies and reported 881 barriers and facilitators. The barriers and facilitators were thematically synthesized and a thematic framework of 20 themes was developed. The quality of the included reviews was assessed and reported. MAIN RESULTS: Several opportunities to increase clinical trial participation, by developing interventions and changing the trial design, derived from an analysis of the thematic framework. That analysis also showed that most of the 20 themes operate mainly as a barrier or as a facilitator, and that most have an effect across medical subjects. As to the quality elements assessed, some reviews complied almost fully but most only partially.
format Online
Article
Text
id pubmed-8358641
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83586412021-08-15 Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews Rodríguez-Torres, Edgardo González-Pérez, Margarita M. Díaz-Pérez, Clemente Contemp Clin Trials Commun Article BACKGROUND: The demand for clinical trial participants is today one of the highest it has ever been and continues to increase. At the same time, subject recruitment continues to be problematic and the major reason for clinical trial premature terminations. The literature on clinical trial recruitment, which spans several decades and includes hundreds of studies, has an abundance of findings that can be synthesized by way of an overview to provide a well-informed and complete picture of the factors that determine subject participation. OBJECTIVES: An overview of the systematic reviews that report barriers and facilitators to clinical trial participation was conducted. The extracted data were synthesized, and a thematic framework of the factors that affect subject participation in clinical trials was developed. The overview extended across medical subjects and demographics. METHODS: Thirty reviews that complied with the inclusion criteria were included. These reviews covered 753 relevant primary studies and reported 881 barriers and facilitators. The barriers and facilitators were thematically synthesized and a thematic framework of 20 themes was developed. The quality of the included reviews was assessed and reported. MAIN RESULTS: Several opportunities to increase clinical trial participation, by developing interventions and changing the trial design, derived from an analysis of the thematic framework. That analysis also showed that most of the 20 themes operate mainly as a barrier or as a facilitator, and that most have an effect across medical subjects. As to the quality elements assessed, some reviews complied almost fully but most only partially. Elsevier 2021-08-03 /pmc/articles/PMC8358641/ /pubmed/34401599 http://dx.doi.org/10.1016/j.conctc.2021.100829 Text en © 2021 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Rodríguez-Torres, Edgardo
González-Pérez, Margarita M.
Díaz-Pérez, Clemente
Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
title Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
title_full Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
title_fullStr Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
title_full_unstemmed Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
title_short Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
title_sort barriers and facilitators to the participation of subjects in clinical trials: an overview of reviews
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358641/
https://www.ncbi.nlm.nih.gov/pubmed/34401599
http://dx.doi.org/10.1016/j.conctc.2021.100829
work_keys_str_mv AT rodrigueztorresedgardo barriersandfacilitatorstotheparticipationofsubjectsinclinicaltrialsanoverviewofreviews
AT gonzalezperezmargaritam barriersandfacilitatorstotheparticipationofsubjectsinclinicaltrialsanoverviewofreviews
AT diazperezclemente barriersandfacilitatorstotheparticipationofsubjectsinclinicaltrialsanoverviewofreviews